,2,3,4,5,6 Indeed, it replicates preferentially in tumor cells due to their interferon (IFN) pathway defects, and the subsequent lysis of infected cells induces the release of tumor antigens, which then stimulate the anti-tumor immune response.2 Here, IFNA1 is linked to neoplasm.